Publications by authors named "Ina Binse"

Claim this Profile
I
Intra-Individual Comparison of I-PET/CT and I-PET/MR Hybrid Imaging of Patients with Resected Differentiated Thyroid Carcinoma: Aspects of Attenuation Correction.
Hong Grafe, Maike E Lindemann, Manuel Weber, Julian Kirchner, Ina Binse

Cancers (Basel)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
18 F-FDG-PET/MRI in patients with Graves' orbitopathy.
Manuel Weber, Cornelius Deuschl, Nikolaos Bechrakis, Lale Umutlu, Gerald Antoch, Ina Binse

Graefes Arch Clin Exp Ophthalmol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of risk factors and prognosis in differentiated thyroid cancer with focus on minimal extrathyroidal extension.
Manuel Weber, Ina Binse, Karin Oebbecke, Tim Brandenburg, Ken Herrmann

BMC Endocr Disord· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Questions and Controversies in the Clinical Application of Tyrosine Kinase Inhibitors to Treat Patients with Radioiodine-Refractory Differentiated Thyroid Carcinoma: Expert Perspectives.
Frederik A Verburg, Holger Amthauer, Ina Binse, Ingo Brink, Andreas Buck

Horm Metab Res· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intraoperative Ga-PSMA Cerenkov Luminescence Imaging for Surgical Margins in Radical Prostatectomy: A Feasibility Study.
Christopher Darr, Nina N Harke, Jan Philipp Radtke, Leubet Yirga, Claudia Kesch, Ina Binse

J Nucl Med· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of 124I PET/CT lesion dosimetry in differentiated thyroid cancer.
Manuel Weber, Ina Binse, James Nagarajah, Andreas Bockisch, Ken Herrmann

Q J Nucl Med Mol Imaging· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk Stratification of Thyroid Nodules Using the Thyroid Imaging Reporting and Data System (TIRADS): The Omission of Thyroid Scintigraphy Increases the Rate of Falsely Suspected Lesions.
Simone Schenke, Philipp Seifert, Michael Zimny, Thomas Winkens, Ina Binse

J Nucl Med· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thyroid stunning in radioiodine-131 therapy of benign thyroid diseases.
Christian Happel, Wolfgang Tilman Kranert, Hanns Ackermann, Ina Binse, Benjamin Bockisch

Endocrine· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changing trends of incidence and prognosis of thyroid carcinoma.
Jamshid Farahati, Uwe Mäder, Elena Gilman, Rainer Görges, Ines Maric, Ina Binse

Nuklearmedizin· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of prompt gamma coincidence correction on absorbed dose estimation in differentiated thyroid cancer using 124I PET/CT imaging.
Roel Wierts, Maurizio Conti, Anouk G G Claessen, Ken Herrmann, Gerrit J Kemerink, Ina Binse

Nucl Med Commun· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative performance of I PET/MR of neck lesions in thyroid cancer patients using I PET/CT as reference.
Walter Jentzen, Jinda Phaosricharoen, Benedikt Gomez, Philipp Hetkamp, Vanessa Stebner, Ina Binse

EJNMMI Phys· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pretherapeutic 124I dosimetry reliably predicts intratherapeutic blood kinetics of 131I in patients with differentiated thyroid carcinoma receiving high therapeutic activities.
Marcus Ruhlmann, Wilfried Sonnenschein, James Nagarajah, Ina Binse, Ken Herrmann

Nucl Med Commun· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radioactive Iodine Therapy for Differentiated Thyroid Cancer: Lessons from Confronting Controversial Literature on Risks for Secondary Malignancy.
Mark Tulchinsky, Ina Binse, Alfredo Campennì, Sabina Dizdarevic, Luca Giovanella

J Nucl Med· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fixed 3.7-GBq I Activity for Metastatic Thyroid Cancer Therapy Ignores Science and History.
Walter Jentzen, Alan E Nahum, Andreas Bockisch, Ina Binse, Mark Tulchinsky

J Nucl Med· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response assessment of bevacizumab therapy in GBM with integrated 11C-MET-PET/MRI: a feasibility study.
Cornelius Deuschl, Christoph Moenninghoff, Sophia Goericke, Julian Kirchner, Susanne Köppen, Ina Binse

Eur J Nucl Med Mol Imaging· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneous 11C-Methionine Positron Emission Tomography/Magnetic Resonance Imaging of Suspected Primary Brain Tumors.
Cornelius Deuschl, Sophia Goericke, Johannes Grueneisen, Lino Morris Sawicki, Juliane Goebel, Ina Binse

PLoS One· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Somatostatin Receptor-Directed PET/CT on the Management of Patients with Neuroendocrine Tumor: A Systematic Review and Meta-Analysis.
Martin Barrio, Johannes Czernin, Stefano Fanti, Valentina Ambrosini, Ina Binse

J Nucl Med· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinguishing synchronous from metachronous manifestation of distant metastases: a prognostic feature in differentiated thyroid carcinoma.
Amir Sabet, Ina Binse, Semih Dogan, Andrea Koch, Sandra J Rosenbaum-Krumme

Eur J Nucl Med Mol Imaging· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
6
68Ga-DOTATOC PET/CT in Patients with Iodine- and 18F-FDG-Negative Differentiated Thyroid Carcinoma and Elevated Serum Thyroglobulin.
Ina Binse, Thorsten D Poeppel, Marcus Ruhlmann, Samer Ezziddin, Rainer Görges

J Nucl Med· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of incomplete surgical clearance of radioiodine sensitive local lymph node metastases diagnosed by post-operative (124)I-NaI-PET/CT in patients with papillary thyroid cancer.
Amir Sabet, Ina Binse, Hong Grafe, Samer Ezziddin, Rainer Görges

Eur J Nucl Med Mol Imaging· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
124I PET Assessment of Response of Bone Metastases to Initial Radioiodine Treatment of Differentiated Thyroid Cancer.
Walter Jentzen, Femke Verschure, Annelie van Zon, Rudie van de Kolk, Roel Wierts, Ina Binse

J Nucl Med· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High Level of Agreement Between Pretherapeutic 124I PET and Intratherapeutic 131I Imaging in Detecting Iodine-Positive Thyroid Cancer Metastases.
Marcus Ruhlmann, Walter Jentzen, Verena Ruhlmann, Cinzia Pettinato, Gloria Rossi, Ina Binse

J Nucl Med· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial [18F]FDG PET/CT in high-risk DTC patients. A three-year follow-up.
Marcus Ruhlmann, Ina Binse, Andreas Bockisch, Sandra J Rosenbaum-Krumme

Nuklearmedizin· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging of differentiated thyroid carcinoma: 124I-PET/MRI may not be superior to 124I-PET/CT.
Ina Binse, Sandra Julia Rosenbaum-Krumme, Andreas Bockisch

Eur J Nucl Med Mol Imaging· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chewing-gum stimulation did not reduce the absorbed dose to salivary glands during radioiodine treatment of thyroid cancer as inferred from pre-therapy (124)I PET/CT imaging.
Walter Jentzen, Marion Richter, James Nagarajah, Thorsten Dirk Poeppel, Wolfgang Brandau, Ina Binse

EJNMMI Phys· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis